NUVB
Nuvation Bio·NYSE
--
--(--)
--
--(--)
NUVB fundamentals
Nuvation Bio (NUVB) Revenue Breakdown: Q3 2025 Business & Regional Performance
Nuvation Bio (NUVB) reported total revenue of 13.12M USD in Q3 2025, with its core business segment Product contributing 58.86%. Regionally, United States remained the largest market, accounting for 58.86% of total revenue. Explore Nuvation Bio's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Nuvation Bio (NUVB) reported total revenue of 13.12M USD in Q3 2025, with its core business segment Product contributing 58.86%. Regionally, United States remained the largest market, accounting for 58.86% of total revenue. Explore Nuvation Bio's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Nuvation Bio's revenue and profit?What guidance did Nuvation Bio's management provide for the next earnings period?What is the revenue and EPS growth rate for Nuvation Bio year over year?What is the market's earnings forecast for Nuvation Bio next quarter?What were the key takeaways from Nuvation Bio's earnings call?What were the key takeaways from Nuvation Bio’s earnings call?Did Nuvation Bio beat or miss consensus estimates last quarter?What is Nuvation Bio's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
